Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Short-Term Debt repayments (2020 - 2024)

Orthofix Medical (OFIX) reported Short-Term Debt repayments of $127.5 million for Q4 2024, up 750.0% quarter-over-quarter from $15.0 million in Q1 2024.

Orthofix Medical (OFIX) has 2 years of Short-Term Debt repayments data on file, last reported at $127.5 million in Q4 2024.

  • For the quarter ending Q4 2024, Short-Term Debt repayments changed N/A year-over-year to $127.5 million; the trailing twelve-month figure through Dec 2024 stood at $142.5 million (changed N/A YoY), and the FY2024 full-year result was $142.5 million, up 80.38% from the prior year.
  • Short-Term Debt repayments for Q4 2024 stood at $127.5 million, up from $15.0 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $127.5 million in Q4 2024 and bottomed at $15.0 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 259.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Orthofix Medical 375.38 Mn 254.51 Mn 139.55 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 127.50 Mn
Dec 31, 2024 127.50 Mn
Mar 31, 2024 15.00 Mn
Mar 31, 2024 15.00 Mn
Sep 30, 2020 100.00 Mn
Sep 30, 2020 100.00 Mn